Global Drug Eluting Beads Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Drug Eluting Beads Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Drug Eluting Beads market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Drug Eluting Beads industry chain, the market status of Hospitals (Oncozene Beads, Quadra Sphere), Specialized Clinics (Oncozene Beads, Quadra Sphere), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Eluting Beads.

Regionally, the report analyzes the Drug Eluting Beads markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Eluting Beads market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Drug Eluting Beads market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Eluting Beads industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Oncozene Beads, Quadra Sphere).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Eluting Beads market.

Regional Analysis: The report involves examining the Drug Eluting Beads market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Eluting Beads market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Drug Eluting Beads:

Company Analysis: Report covers individual Drug Eluting Beads manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Eluting Beads This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialized Clinics).

Technology Analysis: Report covers specific technologies relevant to Drug Eluting Beads. It assesses the current state, advancements, and potential future developments in Drug Eluting Beads areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Eluting Beads market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Drug Eluting Beads market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Oncozene Beads
Quadra Sphere
LC Beads
Others

Market segment by Application
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers

Major players covered
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Drug Eluting Beads product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Drug Eluting Beads, with price, sales, revenue and global market share of Drug Eluting Beads from 2019 to 2024.

Chapter 3, the Drug Eluting Beads competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Drug Eluting Beads breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Drug Eluting Beads market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Eluting Beads.

Chapter 14 and 15, to describe Drug Eluting Beads sales channel, distributors, customers, research findings and conclusion.